Haleon plc Form 6-K Summary
Business context and reporting period
Haleon plc, a consumer healthcare company, furnished this Form 6-K in August 2023. The filing identifies Exhibit 99.1 as a press release entitled “2022 Half Year Results,” dated August 2, 2023. The provided filing text does not include the underlying press release or sufficient operating detail to confirm the applicable reporting period. The request metadata specifies June 30, 2023, but the filing exhibit title refers to 2022.
Financial metrics
The provided text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, guidance, or other financial metrics.
Material changes versus the prior comparable period
No comparative financial or operating information is included in the provided filing text.
Guidance, outlook, risks, and unusual items
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided filing text. The filing states that the report is incorporated by reference into Haleon’s Form F-3 and Form S-8 registration statements, to the extent not superseded by later filings.
Investor verification items
- Obtain and review Exhibit 99.1, the referenced “2022 Half Year Results” press release.
- Verify whether the relevant reporting period is the six months ended June 30, 2022 or June 30, 2023.
- Confirm revenue, earnings, cash flow, margins, debt, liquidity, and any guidance from the complete exhibit.
- Review the complete filing for material risks, contingencies, and unusual items not included in the supplied text.